BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

3 Months Ended

Mar. 31, 2019

Risks And Uncertainties [Abstract]

Summary of Percentages of Sales by Product line

The percentages of the Company’s sales by product line were as follows for the periods indicated:

		Three Months Ended
		March 31,
		2019				2018
Waterlase (laser systems)		31.8			%		35.0		%
Diodes (laser systems)			26.0		%		22.0		%
Imaging systems			5.3		%	5.8			%
Consumables and other			20.5		%	20.3			%
Services		16.4			%	16.9			%
License fees and royalties			—		%		—		%
			100.0		%		100.0		%

Revenue from the Company’s products for the three months ended March 31, 2019 and 2018 are as follows (dollars in thousands):

		Three Months Ended
		March 31,
		2019								2018
Laser systems		$	5,964				57.8	%		$	5,703				57.0	%
Imaging systems			552				5.3	%			583				5.8	%
Consumables and other			2,112				20.5	%			2,034				20.3	%
Services			1,695				16.4	%			1,697				16.9	%
License fees and royalties			3				—	%			3				—	%
Total revenue		$	10,326				100.0	%		$	10,020				100.0	%